Some U.S. States Say Feds Cutting Vaccine Allocations by 40%
- ‘Frustrating’ at a time when states are planning programs
- Federal officials blamed confusion over preliminary numbers
A nurse prepares a Pfizer-BioNTech Covid-19 vaccine at McLeod Health Clarendon Hospitals in Manning, South Carolina.
Photographer: Micah Green/BloombergThis article is for subscribers only.
A rift opened between state and federal officials over Covid-19 vaccine allocations on Friday, adding another layer of complication to the early stages of the U.S. immunization effort.
Several U.S. states including New Jersey, California, Oregon, Nevada, and Washington state said the federal government has cut their expected allotments of the Pfizer Inc.-BioNTech SE vaccine for next week by about 40% without explanation. The Health and Human Services Department disputed that cuts had been made.